Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical (LFCR) FCF Margin: 2009-2025

Historic FCF Margin for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to -10.57%.

  • Lifecore Biomedical's FCF Margin fell 693.00% to 8.92% in Q2 2025 from the same period last year, while for May 2025 it was -10.57%, marking a year-over-year increase of 357.00%. This contributed to the annual value of -10.57% for FY2025, which is 357.00% up from last year.
  • Per Lifecore Biomedical's latest filing, its FCF Margin stood at -10.57% for FY2025, which was up 25.26% from -14.14% recorded in FY2024.
  • Lifecore Biomedical's 5-year FCF Margin high stood at -8.68% for FY2021, and its period low was -47.21% during FY2022.
  • For the 3-year period, Lifecore Biomedical's FCF Margin averaged around -20.80%, with its median value being -14.14% (2024).
  • Per our database at Business Quant, Lifecore Biomedical's FCF Margin slumped by 3,854bps in 2022 and then skyrocketed by 2,355bps in 2024.
  • Yearly analysis of 5 years shows Lifecore Biomedical's FCF Margin stood at -8.68% in 2021, then plummeted by 3,854bps to -47.21% in 2022, then spiked by 952bps to -37.69% in 2023, then skyrocketed by 2,355bps to -14.14% in 2024, then skyrocketed by 357bps to -10.57% in 2025.